Nrc Health (NRC) Cash & Equivalents (2010 - 2026)

Nrc Health's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 1.8% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 1.8% YoY), while the FY2025 annual figure was $4.1 million, down 2.22% from the prior year.
• Cash & Equivalents came in at $2.5 million for Q1 2026 at Nrc Health, down from $4.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $47.3 million in Q1 2022 to a low of $485000.0 in Q2 2024.
• A 5-year average of $12.7 million and a median of $4.2 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents plunged 97.84% in 2024 and jumped 987.42% in 2025, its largest moves.
• Nrc Health's Cash & Equivalents stood at $24.9 million in 2022, then plunged by 73.9% to $6.5 million in 2023, then plunged by 34.88% to $4.2 million in 2024, then dropped by 2.22% to $4.1 million in 2025, then slumped by 38.46% to $2.5 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $2.5 million, $4.1 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison